David Rock has significant experience in capturing exciting, high-growth opportunities by creating advanced technologies to disrupt targeted markets. During his tenure as CEO, David has led the development and release of numerous artificial intelligence products, including the NovoHealth Platform. Prior to becoming NovoDynamics President and CEO in 2005, David was the General Manager and Senior Director of Engineering for the KinetDx Solutions business unit at Siemens Medical USA, Inc. While under Mr. Rock’s management, the business achieved record revenues and received the 2003 Frost & Sullivan Market Penetration Award by capturing over 50% of the echocardiography PACS market. Prior to working in the medical industry, Mr. Rock performed neural network development as a Research Computer Scientist for the U.S. Government; developed graphics software for LucasFilms, Ltd.; and created a commercial programming language for generating computer-aided-design graphics. In addition to his management and technical experience, Mr. Rock has co-authored eight patents. He holds a BA in Economics and Computer Analysis from Valparaiso University and completed the Accelerated Business Management Program at the Emory University Goizueta Business School.
Robert Clark joined NovoDynamics in 2014, after 35 years with General Motors Corporation (GM) during which he held a series of executive positions including corporate planning, automotive components operations, vehicle brand marketing and after sales parts and service. He has significant experience in field sales and service operations, warranty analysis, market analysis, corporate finance and planning, and vehicle distribution. Mr. Clark manages the Company’s NovoAnalytics custom solutions business. His team applies a consultative approach to develop custom tools that help organizations utilize very large, diverse data sets to address complex challenges. Mr. Clark has a Bachelor of Science degree from General Motors Institute (now Kettering University), and an MBA from the Kellogg School of Management at Northwestern University.
Kristin Marsh joined NovoDynamics in March 2005 and is the Vice President of Finance. In this role she oversees all aspects of the accounting and finance function. Ms. Marsh brings NovoDynamics the benefit of more than 13 years of finance and accounting experience in the software and technology industry. Before joining NovoDynamics, Ms. Marsh held the position of Corporate Controller for Aston Business Solutions, a Microsoft business applications provider. Prior to its sale to Geac Computer Corporation (now Extensity) in 2003, Ms. Marsh served as Corporate Controller and Chief Accounting Officer at Comshare, Inc., a publicly traded Corporate Performance Management software company. Ms. Marsh has worked in finance and accounting related positions since 1991, including five years in public accounting. She is a fellow of the Institute of Chartered Accountants in England & Wales (FCA). Ms. Marsh received a BA in Chemistry from St. Olaf College and an MBA from the University of Michigan Business School.
Steven Schlosser has served as a Senior Scientist for NovoDynamics since the Company was founded. In 1997, he co-founded Nonlinear Dynamics, one of the current organization’s predecessors. During his career at NovoDynamics, he has assisted with the development and commercialization of the Company’s optical character recognition and document capture products, as well as contract R&D business developments. Most recently, he has managed the Company’s research collaboration with the University of Michigan Center for Integrative Research in Critical Care (M-CIRCC), which is driving development of the NovoHealth Predictive Analytics Healthcare Platform. Prior to Nonlinear Dynamics, Dr. Schlosser served as Program Director, Research Manager and Department Head at the Environmental Research Institute of Michigan (ERIM) and Senior Scientist at Scipar, Inc.; at both organizations, he led and managed applied research and development of advanced information systems for government and military applications. He has co-authored numerous publications on medical and document imaging technology and materials development and, among other honors, received fellowships from the National Science Foundation and National Defense Education Act. Dr. Schlosser holds a PhD in Mathematics from the State University of New York at Buffalo and a BS in Physics from Rensselaer Polytechnic Institute.
Greg Hunter joined NovoDynamics in October 2019 as Vice President, Business Development and Account Management. Mr. Hunter has worked in the Health Care industry for over 20 years, focusing on improving processes and operations. He served as Vice President, Client Engagement for Cotiviti, a leading solutions and analytics company that leverages clinical and financial datasets to deliver insights that help clients improve health care quality, reduce inefficiency and optimize financial performance. Prior to joining Cotiviti, Mr. Hunter was Senior Director of Payment Integrity for Neighborhood Health Plan of Massachusetts. He is an Accredited Health Care Fraud Investigator certified by the National Health Care Anti-Fraud Association (NHCAA) and holds a professional medical coding credential from the American Academy of Professional Coders (AAPC). Mr. Hunter received his MBA from the Franklin W. Olin Graduate School of Business at Babson College and his BA from Salve Regina University.